Search results for: 'counter drug'

This study presents an analysis of the counter-unmanned aerial systems (C-UAS) market. The market includes the equipment that designers and manufacturers produce to detect, identify, locate, track, and mitigate unmanned aerial systems (UAS). This study segments the market into the defense, government, and commercial sectors and provides forecasts f...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

09 Oct 2019  |  North America  |  Market Research

Global Counter UAS Market, Forecast to 2024

Significant Growth is Being Driven by the Rapid Proliferation of Small Aerial Drones and the Asymmetric Threats They Pose

Infographics

×

Key Issues Addressed

The demand for counter unmanned aircraft systems (C-UAS) continues to grow as the proliferation of small aerial drones produces new threat scenarios on the battlefield and in everyday society. C-UAS operations are becoming a necessity for deployed warfighters and are increasingly valued by commercial and civil end users to provide protection from t...

Drug device combination products are aimed to provide targeted treatment, enable better drug delivery and improve the efficacy of the device and medicine. This research service (RS) showcases some of these emerging drug-device combination products including drug eluting stents and drug loaded /coated orthopedic implants under implantable drug-devic...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...

The growing interest in drug delivery devices is more towards micro needle technology for vaccines and hormones. As healthcare companies focus on the transdermal mode of delivery for insulin, companies developing patch technologies have also received huge funding, indicating that the interest in the industry is shifting toward transdermal drug deli...

28 Aug 2020  |  Global  |  Technology Research

Data Science Impacting the Pharmaceutical Industry

Part I: Drug Discovery Applications

Infographics

×

Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...